
Innova Memphis
Description
Innova Memphis is a prominent venture capital firm based in Memphis, Tennessee, dedicated to fostering the growth of early-stage, high-potential companies within the Mid-South region. The firm strategically focuses its investments across key sectors including Biosciences, Healthcare, Technology, and AgTech, aiming to capitalize on the innovative ecosystems developing in these areas. Innova's investment thesis centers on identifying companies with strong foundational technology and scalable business models that can significantly impact their respective industries.
Typically, Innova Memphis provides initial investments ranging from $250,000 to $1,000,000, positioning itself as a crucial early-stage capital provider. Beyond the initial cheque, the firm reserves additional capital for follow-on investments, demonstrating a commitment to supporting its portfolio companies through subsequent funding rounds as they achieve critical milestones and scale operations. This approach underscores their long-term partnership philosophy, providing sustained financial backing and strategic guidance to help founders navigate the challenges of rapid growth.
Since its inception, Innova Memphis has made a substantial impact on the regional startup landscape. The firm has invested over $50 million into more than 100 companies, playing a vital role in the development of numerous innovative ventures. A testament to the success of their portfolio, these companies have collectively gone on to raise over $1 billion in follow-on capital from other investors, highlighting Innova's ability to identify and nurture businesses with significant future potential. The firm continues to be an active player, with its Innova Fund IV, a $25 million fund, closing in 2020, further solidifying its capacity to support new and emerging enterprises.
Investor Profile
Innova Memphis has backed more than 317 startups, with 0 new investments in the last 12 months alone. The firm has led 65 rounds, about 21% of its total and boasts 9 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Debt Financing, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, Argentina, New Zealand.
- Strong thematic focus on Health Care, Medical Device, Medical.
- Typical check size: $250K – $1M.
Stage Focus
- Seed (43%)
- Debt Financing (14%)
- Series Unknown (12%)
- Convertible Note (12%)
- Series A (8%)
- Pre Seed (8%)
- Series B (2%)
Country Focus
- United States (98%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Biotechnology
- Agriculture
- Software
- Agtech
- Health Diagnostics
- Farming
- Information Technology
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.